Date of entry
* must provide value
Today Y-M-D
Are you a member of the HemOnc.org editorial board?
* must provide value
Yes
No
Please select your name from the dropdown.
If you do not see your name, please select "other" and provide additional details below.
* must provide value
Grace Baek Nicholas Bitz Joshua Brandstadter Elizabeth I. Buchbinder Sotirios Diamantoudis Rachel Feaster Austin Fitts Ashwin Kishtagari Justine Preedit Laura Roccograndi Martin W. Schoen Emily Waite Bradley Yelvington Carolnn Yong Shalin Kothari Francesca Montanari Tarsheen K. Sethi H. Deepika Fernandes Mary Mesnard Brianna Bakow Benjamin F. Tillman Ryan Nguyen Emily A. Mann Eric I. Marks Teja Ganta Laura S. Graham Ali Raza Khaki Alaina J. Brown Gaurav Goyal Jon Arnason Sanjai Sharma Irbaz Bin Riaz Marjorie G. Zauderer Sanjay R. Mohan Seema Nagpal Jeremy L. Warner Peter C. Yang Cameron Beau Hilton Travis Zack Elaine Fan David Noyd Wayne H. Liang Nikki Wood Andrew J. Cowan Mary L. Kwok Samuel M. Rubinstein Danielle S. Bitterman Elizabeth J. Davis Matthew Hadfield Maryam B. Lustberg Leyre Zubiri Bhagirathbhai Dholaria Amit Kulkarni Eric K. Singhi Talal Hilal Other Michael Glover Sandeep Jain Michael Rooney Gayathri Nagaraj Aditya Shreenivas
View equation
Please enter your name and degrees (if applicable):
Is this a new study entry, an update to an existing study, or a new guideline?
New study
Update to an existing study
New guideline
New study
Update to an existing study
New guideline
Does this study have immediate practice-changing implications?
If you are not sure, please select "No".
Yes
No
Please enter the condition:
* must provide value
Acquired Hemophilia A Acute myeloid leukemia, FLT3-positive Acute myeloid leukemia, IDH-mutated Acute myeloid leukemia, NPM1-mutated Acute myeloid leukemia, pediatric Acute myeloid leukemia Acute promyelocytic leukemia Adrenocortical carcinoma Adult T-cell leukemia-lymphoma Allogeneic HSCT Anal cancer Anaplastic glioma Anaplastic large cell lymphoma, pediatric Anaplastic large cell lymphoma Antiphospholipid antibody syndrome Aplastic anemia Appendiceal tumor Atypical hemolytic uremic syndrome Autoimmune cytopenia Autologous HSCT B-cell acute lymphoblastic leukemia, pediatric, Ph-positive B-cell acute lymphoblastic leukemia, pediatric B-cell acute lymphoblastic leukemia, Ph-positive B-cell acute lymphoblastic leukemia B-cell lymphoma of mucosa-associated lymphoid tissue Beta thalassemia Bladder cancer Blastic plasmacytoid dendritic cell neoplasm Bone sarcoma Malignant solid neoplasm, BRAF-mutated Breast cancer, BRCA-mutated Breast cancer, CNS metastases Breast cancer, ER and HER2 co-expressing Breast cancer, ER-positive Breast cancer, HER2-positive Breast cancer, PIK3CA-mutated Breast cancer, triple negative Breast cancer Burkitt lymphoma Carcinoma of unknown primary Castleman disease Cervical cancer Chimeric antigen receptor T cells (CAR-T) Cholangiocarcinoma Chronic lymphocytic leukemia Chronic myeloid leukemia, pediatric Chronic myeloid leukemia Chronic myelomonocytic leukemia Clear cell renal cell carcinoma CNS carcinoma CNS leukemia CNS lymphoma CNS melanoma Cold agglutinin disease Colon cancer, RAS wild-type Colon cancer Colorectal cancer, BRAF-mutated Colorectal cancer, HER2-positive Colorectal cancer, MSI-H or dMMR Colorectal cancer, RAS wild-type Colorectal cancer Cutaneous basal cell carcinoma Cutaneous squamous cell carcinoma Cutaneous T-cell lymphoma Desmoid tumor Diffuse large B-cell lymphoma Malignant solid neoplasm, EGFR-mutated Endometrial cancer Epithelioid sarcoma Malignant solid neoplasm, ERBB2-mutated Malignant solid neoplasm, ERBB3-mutated Erdheim-Chester disease Esophageal adenocarcinoma Esophageal cancer Esophageal squamous cell carcinoma Essential thrombocythemia Ewing sarcoma, pediatric Ewing sarcoma Extranodal NK- and T-cell lymphoma, nasal type Follicular lymphoma Gallbladder cancer Gastric cancer, HER2-positive Gastric cancer Gastrointestinal stromal tumor Gestational trophoblastic neoplasia Giant-cell tumor of bone Glioblastoma Graft versus host disease Hairy cell leukemia Head and neck cancer Hemophagocytic lymphohistiocytosis Heparin-induced thrombocytopenia Hepatoblastoma Hepatocellular carcinoma Hereditary hemorrhagic telangiectasia High-grade B-cell lymphoma High-grade glioma, pediatric HIV-associated lymphoma Hodgkin lymphoma, nodular lymphocyte-predominant Classical Hodgkin lymphoma, pediatric Classical Hodgkin lymphoma Hypereosinophilic syndrome Immune thrombocytopenia Inherited coagulopathy Inherited thrombophilia Juvenile myelomonocytic leukemia Kaposi sarcoma Langerhans cell histiocytosis Large granular lymphocytic leukemia Leiomyosarcoma Light-chain (AL) amyloidosis Liposarcoma Low-grade glioma, pediatric Low-grade glioma Low-grade serous ovarian cancer Malignant peritoneal mesothelioma Malignant pleural mesothelioma Mantle cell lymphoma Marginal zone lymphoma Mediastinal gray-zone lymphoma Medulloblastoma Melanoma Meningioma Merkel cell carcinoma Malignant solid neoplasm, MSI-H or dMMR Multiple myeloma, consolidation and maintenance Multiple myeloma, induction Multiple myeloma, relapsed-refractory Myelodysplastic syndrome Myelofibrosis Nasopharyngeal carcinoma NET of unknown primary Neuroblastoma Neuroendocrine tumor NK- and T-cell lymphoma Non-clear cell renal cell carcinoma Non-Hodgkin lymphoma, pediatric Non-small cell lung cancer, ALK-positive Non-small cell lung cancer, BRAF-mutated Non-small cell lung cancer, CNS metastases Non-small cell lung cancer, EGFR-mutated Non-small cell lung cancer, HER2-mutated Non-small cell lung cancer, KRAS-mutated Non-small cell lung cancer, MET-mutated Non-small cell lung cancer, nonsquamous Non-small cell lung cancer, RET-positive Non-small cell lung cancer, ROS1-positive Non-small cell lung cancer, squamous Non-small cell lung cancer Malignant solid neoplasm, NTRK-mutated Oropharyngeal cancer, HPV-positive Osteosarcoma Ovarian cancer, BRCA-mutated Ovarian cancer Pancreatic cancer, BRCA-mutated Pancreatic cancer Pancreatic NET Papillary renal cell carcinoma Paroxysmal nocturnal hemoglobinuria PEComa Penile cancer Periampullary adenocarcinoma Peripheral T-cell lymphoma Pheochromocytoma Plasma cell leukemia POEMS syndrome Polycythemia vera Post-transplant lymphoproliferative disorder Primary mediastinal B-cell lymphoma Prostate cancer, BRCA-mutated Prostate cancer Rectal cancer Renal cell carcinoma, VHL-associated Renal cell carcinoma Malignant solid neoplasm, RET-mutated Rhabdomyosarcoma Rosai-Dorfman-Destombes disease Sarcomatoid renal cell carcinoma Sickle cell anemia Small cell lung cancer Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) Smoldering multiple myeloma Soft tissue sarcoma Stem cell mobilization Subependymal giant cell astrocytoma Systemic mastocytosis T-cell acute lymphoblastic leukemia, pediatric T-cell acute lymphoblastic leukemia T-cell prolymphocytic leukemia Tenosynovial giant cell tumor Testicular cancer Thrombocytopenia in liver disease Thrombotic microangiopathy Thrombotic thrombocytopenic purpura Thymoma Thyroid cancer, BRAF-mutated Thyroid cancer, differentiated Thyroid cancer, medullary Thyroid cancer, RET-positive Thyroid cancer Malignant solid neoplasm, TMB-H Transformed lymphoma Upper tract urothelial carcinoma Uveal melanoma Vascular sarcoma Venous thromboembolism Vulvar cancer Waldenstrom macroglobulinemia Warm autoimmune hemolytic anemia WHIM syndrome Wilms tumor Other Melanoma, NRAS-mutated Melanoma, BRAF-mutated Melanoma, KIT-mutated Multiple Myeloma T-cell acute lymphoblastic lymphoma T-cell prolymphocytic lymphoma Rhabdomyosarcoma, pediatric Osteosarcoma, pediatric Urothelial Carcinoma Acquired thrombotic thrombocytopenic purpura Alveolar soft part sarcoma Angiosarcoma Colorectal cancer, KRAS-mutated Craniopharyngioma Dermatofibrosarcoma protuberans Inflammatory myofibroblastic tumor Neuroendocrine carcinoma Small bowel adenocarcinoma
Please type the condition here:
* must provide value
Breast Oncology Dermatologic Oncology Endocrine Oncology Gastrointestinal Oncology, Intestinal Gastrointestinal Oncology, Extraintestinal Genitourinary Oncology Gynecologic Oncology Head and Neck Oncology Mesothelioma Neuro-Oncology Sarcoma Thoracic Oncology Site Agnostic Acute Leukemias Myeloproliferative neoplasms and myelodysplastic syndromes Aggressive Lymphomas Indolent Lymphomas Plasma Cell Dyscrasias T-cell and NK-cell neoplasms Lymphoproliferative Disorders Histiocyte Disorders Pediatric CNS Malignancies Pediatric Hematologic Neoplasms Pediatric Solid Tumors Transplant and Immune Effector Cells Hemostasis and Thrombosis Cytopenias Hemolytic Disorders Hemoglobinopathies Other
Please enter the study name here.
If there is no obvious study name, use the convention of first author's last name et al. and the year of publication (e.g., Smith et al. 2020).
Please provide the PubMed identifier here. If the reference is not listed in PubMed, enter 0 here.
* must provide value
Please enter a link to the web page where the publication can be found.
* must provide value
Please provide a clinical trial identifier for the study, if available.
This will usually be a ClinicalTrials.gov identifier, which starts with NCT. Other common registry are ISRCTN and EudraCT.
Is this study randomized or non-randomized?
Randomized
Non-randomized
Please select the design of the randomized trial.
If the design is not in the list, please select other and provide the additional details.
Adaptively Randomized phase 2 Phase 2/3 Phase 3 Phase 3b Phase 3b/4 Pseudo-Mendelian randomization Quasi-randomized Randomized Randomized double-blind Randomized phase 1 Randomized phase 1/2 Randomized phase 1b Randomized phase 1b/2 Randomized phase 2 Randomized phase 2/3 Randomized phase 2b Other
Please enter the study design here.
Please select the design of the non-randomized trial.
If the design is not in the list, please select other and provide the additional details.
Case report Case report review Case series Non-randomized Observational Phase 1 Phase 1/2 Phase 1/2a Phase 1/2b Phase 1b Phase 1b/2 Phase 1b/2a Phase 2 Phase 2 basket trial Phase 2a Phase 2b Phase 4 Propensity score analysis Registry Retrospective Retrospective propensity score-matched Review Screening phase 2 Other
Please enter the study design here.
If you know it, please enter the dates of enrollment here. Please use ISO 8601 format, as follows:
If only years are available, the format is YYYY-YYYY (e.g., 2018-2021)
If year and month but not day are available, the format is YYYY-MM to YYYY-MM (e.g., 2018-01 to 2021-04)
If year, month, and day are available, the format is YYYY-MM-DD to YYYY-MM-DD (e.g., 2018-01-15 to 2021-04-11)
If there is additional information that you would like to share beyond what you've provided above, please provide it here.
Please enter the regimen, to include the drug name, dose, route, frequency, and cycle length.
Submit
Save & Return Later